Restructuring the FDA's Food Program: Promises and Pitfalls

Restructuring the FDA's Food Program: Promises and Pitfalls

Following an outbreak of Cronobacter sakazakii infection in infant formula, the US Food and Drug Administration commissioned a series of reports and then undertook a major reorganization of its food program. This article describes the changes that went into effect on 1 October 2024, why those change...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Foods 2024-10, Vol.13 (20), p.3334
Hauptverfasser: Marzouk, Sammer, Rumalla, Kranti C, Lurie, Peter G
Format: Artikel
Sprache:eng
Schlagworte:
Baby foods
Collaboration
Conflicts of interest
Dietary supplements
Epidemics
FDA approval
Federal regulation
Food
Food programs
Food safety
Food supply
Health aspects
Human Foods Program
infant formula
Infant formulas
Information technology
Inspection
Lurie, Peter
Modernization
Nutrition
Opinion
Organizational structure
Product lines
Public health
public policy
regulation
reorganization
Safety and security measures
US Food and Drug Administration
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Following an outbreak of Cronobacter sakazakii infection in infant formula, the US Food and Drug Administration commissioned a series of reports and then undertook a major reorganization of its food program. This article describes the changes that went into effect on 1 October 2024, why those changes are likely to improve the new Human Foods Program, and additional work that must be undertaken to enhance the agency's impact upon public health.
ISSN:2304-8158
2304-8158
DOI:10.3390/foods13203334